Danaher | DHR - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Agilent USD 25M 0 2026-03
Align Technology USD 16.04M 14.04M 2025-12
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bio Techne USD 2.17M 9K 2025-12
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Boston Scientific USD 90M 0 2026-03
Bruker USD 8.1M 11.9M 2025-12
Charles River Laboratories USD 26.74M 2.97M 2026-03
Danaher USD 63M 8M 2026-03
Dentsply International USD 24M 2M 2026-03
Edwards Lifesciences USD 35.9M 2.7M 2025-12
ESCO Technologies USD 2.88M 2.25M 2025-12
Fortive USD 31.6M 600K 2026-03
Henry Schein USD 39M 0 2026-03
Illumina USD 26M 1000K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Keysight Technologies USD 25M 4M 2026-03
Laboratory Of America USD 55.1M 100K 2026-03
Medtronic USD 176M 5M 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Roper Industries USD 93.3M 3.6M 2025-12
Stryker USD 46.29B 45.68B 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 42M 33.38M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03